Utility of low-dose oral aspirin challenges for diagnosis of Aspirin Exacerbated Respiratory Disease

Podobne zapisy

• Plasma 15-hydroxyeicosatetraenoic acid predicts treatment outcomes in aspirin-exacerbated respiratory disease
  od: Jerschow, Elina, i wsp.
  Wydane: (2017)
• Depression symptoms and quality of life among individuals with Aspirin-Exacerbated Respiratory Disease
  od: Feldman, Jonathan M., i wsp.
  Wydane: (2018)
• The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
  od: Comhair, Suzy A. A., i wsp.
  Wydane: (2018)
• Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
  od: Sehanobish, Esha, i wsp.
  Wydane: (2021)
• COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
  od: White, Andrew A., i wsp.
  Wydane: (2021)